LeviCure
@levicure.com
Levicure Ltd. is an Israeli start-up that aims to provide an effective oral treatment for type 1 diabetes mellitus (T1DM) with patented IP consisting of a combination of three FDA approved drugs.
LeviCure's Company Logos
LeviCure's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#7893B1
Wild Blue Yonder
120, 147, 177
212, 27, 58
32, 17, 0, 31
#2277AB
Matisse
34, 119, 171
203, 67, 40
80, 30, 0, 33
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
About LeviCure
Levicure Ltd. is an Israeli start-up that is dedicated to providing an innovative solution for type 1 diabetes mellitus (T1DM) patients. Our goal is to offer a safe and scalable oral treatment that can significantly reduce insulin requirements and induce remission.
Our patented combination therapy consists of three FDA approved drugs along with GABA. Extensive scientific evidence, including clinical proof-of-concept studies in T1D patients and animal models, has shown that our treatment can restore the body's insulin production, leading to remission in some cases. By initiating treatment within six months of T1D diagnosis, our therapy has achieved the best results for remission.
Levicure's non-invasive, orally administered medication has the potential to greatly improve the quality of life for T1D patients, reducing complications and providing a safer and more convenient alternative to daily insulin injections. With over 18 million people worldwide affected by T1D, our scalable and affordable solution has a competitive advantage over other therapies
Company type
Privately Held
Year founded
2020
Company size
2-10 employees
